SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-025867
Filing Date
2021-02-02
Accepted
2021-02-02 16:15:54
Documents
4
Period of Report
2021-01-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d123692d8k.htm 8-K 24849
2 EX-10.1 d123692dex101.htm EX-10.1 58064
3 EX-99.1 d123692dex991.htm EX-99.1 11623
4 GRAPHIC g123692dsp012.gif GRAPHIC 3053
  Complete submission text file 0001193125-21-025867.txt   99775
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 21581644
SIC: 2836 Biological Products, (No Diagnostic Substances)